งานวิจัย (ย้อนหลัง 5 ปี 2019-2023)

นานาชาติ

1. Khaeso K, Komvilaisak P, Chainansamit SO, Nakkam N, Suwannaying K, Kuwatjanakul P, Hikino K, Dornsena A, Kanjanawart S, Laoaroon N, Vannaprasaht S, Taketani T, Tassaneeyakul W. NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine. Drug Metabolism and Pharmacokinetics. 2022 Apr;43: 100436.

2. Khaeso K, Nakkam N, Komwilaisak P, Wongmast P, Chainansamit SO, Dornsena A, Kanjanawart S, Vannaprasaht S, Tassaneeyakul W. Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients. J Pediatr Genet. 2021 Mar;10(1):29-34.

3. Boonsom S, Vannaprasaht S, Preechagoon Y. Therapeutic dosage ranges and chronic adverse effects of tacrolimus in thai kidney transplant patients. International Journal of Applied Pharmaceutics. 2021 Jan;13(Special Issue 1):13-16.

4. Sirirat Anutrakulchai, Cholatip Pongskul, Kittrawee Kritmetapak, Chulaporn Limwattananon, Suda Vannaprasaht. Therapeutic Concentration Achievement and Allograft Survival Comparing Usage of Conventional Tacrolimus Doses and CYP3A5 Genotype-Guided Doses in Renal Transplantation Patients. Br J Clin Pharmacol. Sep 2019;85(9):1964-1973.

5. Anutrakulchai S, Pongskul C, Kritmetapak K, Limwattananon C, Vannaprasaht S. Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype‐guided doses in renal transplantation patients. Br J Clin Pharmacol. 2019 May 11.

ระดับชาติ

1. Kanyarat Khaeso, Nontaya Nakkam, Sirimas Kanjanawart, Suda Vannaprasaht, Patcharee Komvilaisak, Wichittra Tassaneeyakul. Pharmacogenetics of Thiopurine Drugs: Role of Thiopurine SMethyltransferase and Nucleoside Diphosphate-Linked Moiety X Motif 15 Genetic Polymorphisms on Drugs-induced Myelosuppression. Thai J Pharmacol 2019 June 13;41(No. 1):68-82.